Evidence map›Paper›PMID 30021828›Full record

ArticleJournal of clinical microbiology2018

Detection of (1,3)-β-d-Glucan in Cerebrospinal Fluid in Histoplasma Meningitis.

Thein Myint, Felicia C Chow, Karen C Bloch, Luke Raymond-Guillen, Thomas E Davis, Patty W Wright, Laila Woc-Colburn, Raed N Khairy, Alan C Street, Tomotaka Yamamoto and 3 more

Open access · bronzeAbstract readEvaluation Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Single and Repeated Episodes ofFrontiers in microbiology · 2021
    Article
  6. Review
  7. Review
  8. Central Nervous System Infection withJournal of fungi (Basel, Switzerland) · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 3 countries.

Thein MyintDivision of Infectious Diseases, Department of Internal Medicine, University of Kentucky, Lexington, Kentucky, USA thein.myint3@uky.edu.
Felicia C ChowDepartment of Neurology, University of California, San Francisco, San Francisco, California, USA.
Karen C BlochDivision of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Luke Raymond-GuillenDivision of Infectious Diseases, Department of Internal Medicine, Indiana University, Indianapolis, Indiana, USA.
Thomas E DavisDepartment of Pathology and Laboratory Medicine, Indiana University, Indianapolis, Indiana, USA.
Patty W WrightDivision of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Laila Woc-ColburnDivision of Infectious Diseases, Department of Internal Medicine, Baylor College of Medicine, Houston, Texas, USA.
Raed N KhairySparks Clinic, Fort Smith, Arkansas, USA.
Alan C StreetVictorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Tomotaka YamamotoDepartment of Neurology, University of Tokyo Hospital, Tokyo, Japan.
Amanda AlbersMiraVista Diagnostics, Indianapolis, Indiana, USA.
L Joseph WheatMiraVista Diagnostics, Indianapolis, Indiana, USA.
Chadi A HageDivision of Pulmonary and Critical Care Medicine, Thoracic Transplantation Program, Indiana University-School of Medicine, Indianapolis, Indiana, USA.
Indiana University – Purdue University Indianapolis · USVanderbilt University Medical Center · USBaylor College of Medicine · USSmith Clinic · USThe Royal Melbourne Hospital · AUUniversity of California, San Francisco · USUniversity of Kentucky · USUniversity of Tokyo Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The diagnosis of central nervous system (CNS) histoplasmosis is often difficult. Although cerebrospinal fluid (CSF) (1,3)-β-d-glucan (BDG) is available as a biological marker for the diagnosis of fungal meningitis, there are limited data on its use for the diagnosis of

Indexed as

Adultbeta-GlucansBiomarkersClinical Laboratory TechniquesHistoplasmaHistoplasmosisHumansMeningitis, FungalProteoglycansReagent Kits, DiagnosticROC Curvebeta-GlucansBiomarkerspolysaccharide-KProteoglycansReagent Kits, Diagnostic(1,3)-β-d-glucancerebrospinal fluidHistoplasmameningitis

Identifiers

PMID30021828
PMCPMC6156302
OpenAlexW2884505657

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.